{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:08:09Z","timestamp":1792030089941,"version":"4.4.0"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1014174","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000}}],"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Special Fund for the Construction of Innovative Provinces in Hunan Province","award":["2023SK2026"],"award-info":[{"award-number":["2023SK2026"]}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>\n                    Glomerulonephritis (GN) is an immune-mediated kidney disorder that causes glomerular injury, progressive renal dysfunction, and end-stage kidney disease. Traditional treatments such as corticosteroids and immunosuppressants are limited by variable efficacy and severe adverse effects, highlighting the need for novel therapeutic targets and personalized strategies. We performed a systematic multi-omics Mendelian randomization (MR) analysis applying established proteomic and transcriptomic quantitative trait loci (pQTL\/eQTL) resources to genome-wide association studies (GWAS) of four GN subtypes: acute, chronic, IgA nephropathy, and membranous nephropathy. Bayesian colocalization was used to strengthen causal inference, while independent replication and meta-analysis were conducted using the FinnGen cohort. Mouse knockout phenotypes, drug reposition, and computational pharmacology algorithm were applied to evaluate translational potential. Proteomic-wide MR revealed\n                    <jats:italic>MTR<\/jats:italic>\n                    as protective in chronic GN and\n                    <jats:italic>HCK<\/jats:italic>\n                    as a risk factor for membranous nephropathy, whereas\n                    <jats:italic>CD302<\/jats:italic>\n                    and\n                    <jats:italic>CDKN1B<\/jats:italic>\n                    showed protective effects. Transcriptomic-wide MR identified candidate genes across GN subtypes:\n                    <jats:italic>RECQL<\/jats:italic>\n                    ,\n                    <jats:italic>BRSK2<\/jats:italic>\n                    , and\n                    <jats:italic>MGP<\/jats:italic>\n                    in acute GN;\n                    <jats:italic>AFM<\/jats:italic>\n                    ,\n                    <jats:italic>CFHR5<\/jats:italic>\n                    , and\n                    <jats:italic>EPHB2<\/jats:italic>\n                    in chronic GN;\n                    <jats:italic>IL6R<\/jats:italic>\n                    ,\n                    <jats:italic>MBL2<\/jats:italic>\n                    , and\n                    <jats:italic>PRSS3<\/jats:italic>\n                    in IgA nephropathy; and\n                    <jats:italic>TIMP4<\/jats:italic>\n                    ,\n                    <jats:italic>HCK<\/jats:italic>\n                    , and\n                    <jats:italic>PEAR1<\/jats:italic>\n                    in membranous nephropathy. Bayesian colocalization analysis provided strong support for shared causal variants (PPH4\u2009&gt;\u20090.8) for\n                    <jats:italic>HCK<\/jats:italic>\n                    ,\n                    <jats:italic>CD302<\/jats:italic>\n                    ,\n                    <jats:italic>TIMP4<\/jats:italic>\n                    ,\n                    <jats:italic>PEAR1<\/jats:italic>\n                    ,\n                    <jats:italic>PARP1<\/jats:italic>\n                    , and\n                    <jats:italic>FHIT<\/jats:italic>\n                    . Replication and meta-analysis in the FinnGen cohort provided additional consistency across datasets, while downstream translational annotations highlighted\n                    <jats:italic>IL6R<\/jats:italic>\n                    ,\n                    <jats:italic>MBL2<\/jats:italic>\n                    ,\n                    <jats:italic>C5<\/jats:italic>\n                    , and\n                    <jats:italic>CD55<\/jats:italic>\n                    as potential hub targets within immune and complement-related pathways. This integrative multi-omics study provides novel insights into the genetic architecture and therapeutic landscape of GN, identifying potential therapeutic targets that may inform precision nephrology and drug repurposing. Notably, most targets supported by colocalization, mouse knockout phenotypes, and drug repurposing evidence were predominantly identified in membranous nephropathy, suggesting a particularly tractable genetic and therapeutic architecture for this subtype.\n                  <\/jats:p>","DOI":"10.1371\/journal.pcbi.1014174","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:46:03Z","timestamp":1776361563000},"page":"e1014174","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization"],"prefix":"10.1371","volume":"22","author":[{"given":"Guoqiang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Jianhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashu","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinhuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4803-0833","authenticated-orcid":true,"given":"Dianjie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"7","key":"pcbi.1014174.ref001","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41577-022-00816-y","article-title":"Glomerulonephritis: immunopathogenesis and immunotherapy","volume":"23","author":"HJ Anders","year":"2023","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"pcbi.1014174.ref002","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.kint.2016.04.026","article-title":"The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis","volume":"90","author":"JB Wetmore","year":"2016","journal-title":"Kidney Int"},{"issue":"1","key":"pcbi.1014174.ref003","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-021-00303-z","article-title":"Membranous nephropathy","volume":"7","author":"P Ronco","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"pcbi.1014174.ref004","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s40265-023-01855-y","article-title":"Update on the application of monoclonal antibody therapy in primary membranous nephropathy","volume":"83","author":"L Deng","year":"2023","journal-title":"Drugs"},{"issue":"11","key":"pcbi.1014174.ref005","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/ndt\/gfad146","article-title":"IgA nephropathy in adults-treatment standard","volume":"38","author":"PJ Gleeson","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"pcbi.1014174.ref006","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/0272-6386(95)90568-5","article-title":"A review of therapeutic studies of idiopathic membranous glomerulopathy","volume":"25","author":"SL Hogan","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"pcbi.1014174.ref007","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.kint.2025.01.014","article-title":"Treatment of patients with IgA nephropathy: a call for a new paradigm","volume":"107","author":"J Floege","year":"2025","journal-title":"Kidney Int"},{"issue":"1","key":"pcbi.1014174.ref008","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41581-024-00885-3","article-title":"The pathogenesis of IgA nephropathy and implications for treatment","volume":"21","author":"CK Cheung","year":"2025","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"pcbi.1014174.ref009","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","article-title":"Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression","volume":"53","author":"U V\u00f5sa","year":"2021","journal-title":"Nat Genet"},{"issue":"12","key":"pcbi.1014174.ref010","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","article-title":"Large-scale integration of the plasma proteome with genetics and disease","volume":"53","author":"E Ferkingstad","year":"2021","journal-title":"Nat Genet"},{"issue":"3","key":"pcbi.1014174.ref011","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2215\/CJN.14031119","article-title":"GWAS-based discoveries in IgA nephropathy, membranous nephropathy, and steroid-sensitive nephrotic syndrome","volume":"16","author":"E Sanchez-Rodriguez","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"pcbi.1014174.ref012","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement","volume":"326","author":"VW Skrivankova","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"pcbi.1014174.ref013","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13062-025-00631-0","article-title":"Identification of druggable targets in acute kidney injury by proteome- and transcriptome-wide Mendelian randomization and bioinformatics analysis","volume":"20","author":"J Liu","year":"2025","journal-title":"Biol Direct"},{"issue":"10","key":"pcbi.1014174.ref014","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/s41588-021-00931-x","article-title":"A cross-population atlas of genetic associations for 220 human phenotypes","volume":"53","author":"S Sakaue","year":"2021","journal-title":"Nat Genet"},{"issue":"383","key":"pcbi.1014174.ref015","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1166","article-title":"The druggable genome and support for target identification and validation in drug development","volume":"9","author":"C Finan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"pcbi.1014174.ref016","doi-asserted-by":"crossref","DOI":"10.1186\/s12302-025-01189-4","article-title":"Long-term impact of per- and polyfluoroalkyl substances on kidney health: a large-scale genetic study","volume":"37","author":"D Zeng","year":"2025","journal-title":"Environ Sci Eur"},{"issue":"7708","key":"pcbi.1014174.ref017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-018-0175-2","article-title":"Genomic atlas of the human plasma proteome","volume":"558","author":"BB Sun","year":"2018","journal-title":"Nature"},{"issue":"3","key":"pcbi.1014174.ref018","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies","volume":"40","author":"CRP CHD Genetics Collaboration","year":"2011","journal-title":"Int J Epidemiol"},{"key":"pcbi.1014174.ref019","doi-asserted-by":"crossref","first-page":"146096","DOI":"10.1016\/j.ijbiomac.2025.146096","article-title":"Molecular characterization and functional prioritization of CD46, IL6R, KLRC1, LEAP2 and SMOX as candidate targets in acute kidney injury","volume":"320","author":"J Liu","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"pcbi.1014174.ref020","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy163","article-title":"Evaluating the potential role of pleiotropy in Mendelian randomization studies","volume":"27","author":"G Hemani","year":"2018","journal-title":"Hum Mol Genet"},{"issue":"2","key":"pcbi.1014174.ref021","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"J Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"5","key":"pcbi.1014174.ref022","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases","volume":"50","author":"M Verbanck","year":"2018","journal-title":"Nat Genet"},{"issue":"11","key":"pcbi.1014174.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"G Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"pcbi.1014174.ref024","doi-asserted-by":"crossref","first-page":"104494","DOI":"10.1016\/j.ebiom.2023.104494","article-title":"Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses","volume":"89","author":"J Chen","year":"2023","journal-title":"EBioMedicine"},{"issue":"11","key":"pcbi.1014174.ref025","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"P Shannon","year":"2003","journal-title":"Genome Res"},{"issue":"6","key":"pcbi.1014174.ref026","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s11255-013-0432-0","article-title":"MTHFR, MTR and MTRR polymorphisms and risk of chronic kidney disease in Japanese: cross-sectional data from the J-MICC Study","volume":"45","author":"A Hishida","year":"2013","journal-title":"Int Urol Nephrol"},{"issue":"19","key":"pcbi.1014174.ref027","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.3390\/diagnostics13193158","article-title":"Clinical significance of adropin and afamin in evaluating renal function and cardiovascular health in the presence of CKD-MBD biomarkers in chronic kidney disease","volume":"13","author":"R Kaur","year":"2023","journal-title":"Diagnostics (Basel)"},{"issue":"11","key":"pcbi.1014174.ref028","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2217\/bmm-2018-0126","article-title":"Urine afamin and afamin-creatinine ratio as biomarkers for kidney injury","volume":"12","author":"L Pang","year":"2018","journal-title":"Biomark Med"},{"key":"pcbi.1014174.ref029","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diabres.2018.02.034","article-title":"Urinary afamin levels are associated with the progression of diabetic nephropathy","volume":"147","author":"Y Kaburagi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"pcbi.1014174.ref030","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.kint.2018.02.023","article-title":"Circulating complement factor H-related protein 5 levels contribute to development and progression of IgA nephropathy","volume":"94","author":"L Zhu","year":"2018","journal-title":"Kidney Int"},{"issue":"17","key":"pcbi.1014174.ref031","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1042\/CS20210644","article-title":"Key role for EphB2 receptor in kidney fibrosis","volume":"135","author":"Z Huang","year":"2021","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"pcbi.1014174.ref032","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1038\/s41467-023-40086-3","article-title":"HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy","volume":"14","author":"M Chen","year":"2023","journal-title":"Nat Commun"},{"issue":"7034","key":"pcbi.1014174.ref033","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nature03466","article-title":"Generation and annotation of the DNA sequences of human chromosomes 2 and 4","volume":"434","author":"LW Hillier","year":"2005","journal-title":"Nature"},{"issue":"4","key":"pcbi.1014174.ref034","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1038\/ki.1996.432","article-title":"Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis","volume":"50","author":"SJ Shankland","year":"1996","journal-title":"Kidney Int"},{"key":"pcbi.1014174.ref035","doi-asserted-by":"crossref","first-page":"14755","DOI":"10.2147\/JIR.S545422","article-title":"TIMP4 as a potential complementary biomarker and therapeutic target in membranous nephropathy: a multi-omics investigation with clinical validation","volume":"18","author":"Q Chen","year":"2025","journal-title":"J Inflamm Res"},{"issue":"5","key":"pcbi.1014174.ref036","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1172\/JCI200523348","article-title":"Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis","volume":"115","author":"V Vielhauer","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"pcbi.1014174.ref037","doi-asserted-by":"crossref","first-page":"12429","DOI":"10.1038\/s41598-021-91745-8","article-title":"Deletion of the lactoperoxidase gene causes multisystem inflammation and tumors in mice","volume":"11","author":"J Yamakaze","year":"2021","journal-title":"Sci Rep"},{"issue":"7","key":"pcbi.1014174.ref038","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1161\/ATVBAHA.124.321682","article-title":"PARylation of POLG mediated by PARP1 accelerates Ferroptosis-Induced vascular calcification via activating Adora2a\/Rap1 signaling","volume":"45","author":"Y Yang","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"pcbi.1014174.ref039","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1038\/s12276-024-01322-y","article-title":"CBL-b E3 ligase-mediated neddylation and activation of PARP-1 induce vascular calcification","volume":"56","author":"D-H Kwon","year":"2024","journal-title":"Exp Mol Med"},{"issue":"6","key":"pcbi.1014174.ref040","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/s43587-024-00627-x","article-title":"Converting cell death into senescence by PARP1 inhibition improves recovery from acute oxidative injury","volume":"4","author":"J Nehme","year":"2024","journal-title":"Nat Aging"},{"issue":"5","key":"pcbi.1014174.ref041","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/HYPERTENSIONAHA.112.199240","article-title":"Genetic variants in Arhgef11 are associated with kidney injury in the Dahl salt-sensitive rat","volume":"60","author":"JM Williams","year":"2012","journal-title":"Hypertension"},{"issue":"11","key":"pcbi.1014174.ref042","doi-asserted-by":"crossref","first-page":"3175","DOI":"10.1681\/ASN.2017010076","article-title":"Mannose-binding lectin levels could predict prognosis in IgA nephropathy","volume":"28","author":"W-Y Guo","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"pcbi.1014174.ref043","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.4049\/jimmunol.167.5.2791","article-title":"Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis","volume":"167","author":"H Sogabe","year":"2001","journal-title":"J Immunol"},{"issue":"3","key":"pcbi.1014174.ref044","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00243.2019","article-title":"Perivascular CD73+ cells attenuate inflammation and interstitial fibrosis in the kidney microenvironment","volume":"317","author":"HM Perry","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"pcbi.1014174.ref045","doi-asserted-by":"crossref","DOI":"10.1152\/ajpcell.00285.2019","article-title":"Cell type- and tissue-specific functions of ecto-5\u2019-nucleotidase (CD73)","volume":"317","author":"M Minor","year":"2019","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"pcbi.1014174.ref046","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00291.2018","article-title":"Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model","volume":"316","author":"S Colon","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"pcbi.1014174.ref047","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S1470-2045(02)00931-2","article-title":"FHIT: from gene discovery to cancer treatment and prevention","volume":"3","author":"Y Pekarsky","year":"2002","journal-title":"Lancet Oncol"},{"issue":"3","key":"pcbi.1014174.ref048","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/ndt\/gfae173","article-title":"IgA class-switched CD27-CD21+ B cells in IgA nephropathy","volume":"40","author":"A Popova","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"pcbi.1014174.ref049","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","article-title":"Interleukin-6 signaling pathway and its role in kidney disease: an update","volume":"8","author":"H Su","year":"2017","journal-title":"Front Immunol"},{"issue":"4","key":"pcbi.1014174.ref050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/nep.12381","article-title":"Association of a polymorphism of the interleukin 6 receptor gene with chronic kidney disease in Japanese individuals","volume":"20","author":"H Horibe","year":"2015","journal-title":"Nephrology (Carlton)"},{"issue":"18","key":"pcbi.1014174.ref051","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008604","article-title":"ADAM23 in cardiomyocyte inhibits cardiac hypertrophy by targeting FAK - AKT signaling","volume":"7","author":"M Xiang","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"25","key":"pcbi.1014174.ref052","article-title":"Shear stress drives the cleavage activation of protease-activated Receptor 2 by PRSS3\/Mesotrypsin to promote invasion and metastasis of circulating lung cancer cells","volume":"10","author":"M Zhou","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"pcbi.1014174.ref053","doi-asserted-by":"crossref","first-page":"970744","DOI":"10.3389\/fmmed.2022.970744","article-title":"The vascular protective effect of matrix Gla protein during kidney injury","volume":"2","author":"Y Kida","year":"2022","journal-title":"Front Mol Med"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1014174","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014174","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T18:00:47Z","timestamp":1777053647000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1014174"}},"subtitle":[],"editor":[{"given":"Arli Aditya","family":"Parikesit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":53,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1014174","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}